Rchr
J-GLOBAL ID：200901021239585804
Update date: Dec. 18, 2024
Endou Takashi
エンドウ タカシ | Endou Takashi
Affiliation and department：
Job title：
Assistant Professor / Research Associate / Instructor
MISC (26)：
-
T Yamauchi, M Watanabe, H Hasegawa, S Yamamoto, T Endo, Y Kabeshima, K Yorozuya, K Yamamoto, M Kitajima. Serrated adenoma developing into advanced colon cancer in 2 years. JOURNAL OF GASTROENTEROLOGY. 2002. 37. 6. 467-470
-
T Endo, M Toda, M Watanabe, Y Iizuka, T Kubota, M Kitajima, Y Kawakami. In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer. CANCER GENE THERAPY. 2002. 9. 2. 142-148
-
S Narai, M Watanabe, H Hasegawa, H Nishibori, T Endo, T Kubota, M Kitajima. Significance of transforming growth factor beta 1 as a new tumor marker for colorectal cancer. INTERNATIONAL JOURNAL OF CANCER. 2002. 97. 4. 508-511
-
S Narai, M Watanabe, H Hasegawa, H Nishibori, T Endo, T Kubota, M Kitajima. Significance of transforming growth factor beta 1 as a new tumor marker for colorectal cancer. INTERNATIONAL JOURNAL OF CANCER. 2002. 97. 4. 508-511
-
T Yamauchi, M Watanabe, T Kubota, H Hasegawa, Y Ishii, T Endo, Y Kabeshima, K Yorozuya, K Yamamoto, M Mukai, et al. Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer. DISEASES OF THE COLON & RECTUM. 2002. 45. 1. 98-103
ｍore...
Lectures and oral presentations (102)：
-
A novel combination therapy of radiation with cancer vaccine using a mutant HSV for the treatment of colon carcinoma
(Annual Meeting of American Association for Cancer Research 2002)
-
A novel combination therapy of radiation with cancer vaccine using a mutant HSV for the treatment of colon carcinoma
(Annual Meeting of American Association for Cancer Research 2002)
-
胃癌の5-fluorouracil感受性におけるnucleoside transporter mRNAの有用性
(第34回制癌剤適応研究会 2001)
-
COX-2選択的阻害剤(JTE-522)を用いた大腸癌肝転移抑制効果の検討
(第34回制癌剤適応研究会 2001)
-
大腸癌におけるCOX-2発現-予後を予測するマーカーとしての可能性-
(第34回制癌剤適応研究会 2001)
ｍore...
Return to Previous Page
